2022 Legislative Memos
Government Programs
A.6058/S.5474 – New York Health Act
Health Insurance Coverage Mandates
A.3132/S.1832 – Complex Rehabilitation Technology
S.4934/A.2451 – Coverage for Asthma
A.242/S.8837 – Coverage for Medical Marijuana
A.9150/S.8156 – Additional Breast Cancer Screenings
A.9054-B/S.8549 – Coverage for Fibroids
Health Insurance Plan Management and Operations
A.879/S.8113 – Clinical Peer Reviewer
S.2121B/A.289B – Medically Fragile Coverage
A.832A/S.3231 – HMO In Network Referrals
S.5299/A.1741 – Copay Accumulator
S.7263/A.2519 – Request for Alternative Contact
S.6920 – Utilization Review Automatic Renewal
A.7129-A/S.6435.B – Utilization Review and Prior-Authorization Restrictions
Pharmaceuticals
S.4532/A.4667 – Opioid Abuse Deterrent
S.1413/A.2383 – Insulin Cost Cap
S.431-A/A.187 – Medicaid Prescription Synchronization
A.372/S.5960 – Prohibit Opioid Treatment Program Copay
Provider Rights and Reimbursement
S.5505/A.6256 – Telehealth Payment Parity
A.7320/S.6534A – Primary Care Reform
A.5368A – DME Reimbursement Parity
A.4177/S.2528 – Termination of Providers
A.1316/S.1573 – Behavioral Health Contracts
2021 Legislative Memos
Health Insurance Coverage Mandates
Health Insurance Plan Management and Operations
- A.879/S.599 – Clinical Peer Reviewer
- A.4668/S.4111 – Prohibit Mid-Year Drug Formulary Changes
- S.2008 – Notice of Partial Approval
- S.5299/A.1741 – Copay Accumulator
- S.21210-B/A.289-B – Medically Fragile Children
Pharmaceuticals
- S.3566/A.5854A – Mail Order Pharmacy
- S.4532/A.4667 – Opioid Abuse Deterrent
- S.7252 – “White Bagging”
- S.6603/A.7598 – Managed Care Organizations and Pharmacy Benefit Manager Fees
- A.372/S.5960 – Prohibit Opiod Treatment Program Copay
- S.1413/A.2382 – Capping Cost Sharing for Insulin
Provider Rights and Reimbursement
- A.1523/S.2212 – CHP Discrimination Against Non-Par Providers
- A.1316/S.1573 – Behavioral Health Contracts
- A.5185/S.2533 – Home Care Prompt Pay
- S.5505/A.6256 – Telehealth Payment Parity
- A.5368A – Durable Medical Equipment Reimbursement Parity
- S.3556 – Non Participating Ambulance Reimbursement
Miscellaneous
2021 Legislative Memos
Health Insurance Coverage Mandates
Health Insurance Plan Management and Operations
- A.879/S.599 – Clinical Peer Reviewer
- A.4668/S.4111 – Prohibit Mid-Year Drug Formulary Changes
- S.2008 – Notice of Partial Approval
- S.5299/A.1741 – Copay Accumulator
- S.21210-B/A.289-B – Medically Fragile Children
Pharmaceuticals
- S.3566/A.5854A – Mail Order Pharmacy
- S.4532/A.4667 – Opioid Abuse Deterrent
- S.7252 – “White Bagging”
- S.6603/A.7598 – Managed Care Organizations and Pharmacy Benefit Manager Fees
- A.372/S.5960 – Prohibit Opiod Treatment Program Copay
- S.1413/A.2382 – Capping Cost Sharing for Insulin
Provider Rights and Reimbursement
- A.1523/S.2212 – CHP Discrimination Against Non-Par Providers
- A.1316/S.1573 – Behavioral Health Contracts
- A.5185/S.2533 – Home Care Prompt Pay
- S.5505/A.6256 – Telehealth Payment Parity
- A.5368A – Durable Medical Equipment Reimbursement Parity
- S.3556 – Non Participating Ambulance Reimbursement
Miscellaneous
2020 Legislative Memos
Health Insurance Plan Management and Operations
- A.9086/S.7525 – Nursing Home Eligibility Determinations
- A.9085/S.7159 – Notice of Partial Approval
- A.2832/S.67 – Domestic Violence Victim Request for Alternative Contact
- A.3076/S.8844 – Clinical Peer Review
- A.9003/S.7569 – Complex Rehabilitation Technology for Medicaid
- S.1408A – Municipality to Join County Self-Insured Plan
Pharmaceuticals
- S.7115/A.9034 – Partial Fill Authorization
- A.10821/S.8255 – $30 Insulin Out of Pocket Cap
- A.8665/S.6646 – Online EPIC Application
- S.6397 – Abuse Deterrent Formulations for Opioids
- S.7109/A.9012 – Medicaid Prescription Synchronization
- S.6492A/A.8533 – $100 Insulin Out of Pocket Cap
- A.9634/S.7699 – Medicaid Managed Care Coverage of Medication Assisted Treatment
- A.9902/S.7828 – Pharmacy Benefit Manager Fiduciary and Licensure
Provider Rights and Reimbursement
View Legislative memos:
2023 LEGISLATIVE MEMOS
Health Insurance Coverage Mandates
- S.200 – Obstetric and Gynecological Care
- A.4713/S.2568 – Coverage of Medical Marijuana
- A.3408/S.3468 – Complex Rehab Tech
- S.4889 – Coverage for Asthma
- A.2516 – Dense Beast Tissue
- A.4232/S.3433 – Complex Rehab Tech
- A.6898/S.3402 – Utilization Review Automatic Approval
- A.859/S.2680 – Gold Carding
- A.1696/S.2465 – 120-Day Window for Additional Breast Exams
- A.2898A – Coverage for Neuropsych Exams for Dyslexia
- A.1673A/S.1196A – Coverage of Biomarker Testing
- A.250A/S.1466 – Non-Par Ambulance Reimbursement
Health Insurance Plan Management and Operations
- A.901/S.1267 – Step Therapy UR Protocol
- A.1777/S.3282 – Termination of Providers
- A.848 – EHR Sharing
- S.4922 – Prohibiting Approved Organizations in the Child Health Insurance Plan From Limiting the Participation of Certain Health Care Providers
- A.7268/S.3400 – UR and Pre-Authorization Restrictions
- A.5129/S.6576 – Disaffiliated Provider Coverage
- A.6019/S.4785 – Collective Negotiations with Plans
- A.7393/S.7477 – MCO Excess Reserves Extender
- A.5381/S.6075 – Actuarial Review of Rates
Pharmaceuticals
Miscellaneous
2022 LEGISLATIVE MEMOS
Government Programs
Health Insurance Coverage Mandates
- A.3132/S.1832 – Complex Rehabilitation Technology
- S.4934/A.2451 – Coverage for Asthma
- A.242/S.8837 – Coverage for Medical Marijuana
- A.9150/S.8156 – Additional Breast Cancer Screenings
- A.9054-B/S.8549 – Coverage for Fibroids
Health Insurance Plan Management and Operations
- A.879/S.8113 – Clinical Peer Reviewer
- S.2121B/A.289B – Medically Fragile Coverage
- A.832A/S.3231 – HMO In Network Referrals
- A.3276/S.5909 – Step Therapy
- S.5299/A.1741 – Copay Accumulator
- S.7263/A.2519 – Request for Alternative Contact
- S.6920 – Utilization Review Automatic Renewal
- A.7129-A/S.6435.B – Utilization Review and Prior-Authorization Restrictions
Pharmaceuticals
- S.4532/A.4667 – Opioid Abuse Deterrent
- S.1413/A.2383 – Insulin Cost Cap
- S.431-A/A.187 – Medicaid Prescription Synchronization
- A.372/S.5960 – Prohibit Opioid Treatment Program Copay
Provider Rights and Reimbursement
2021 LEGISLATIVE MEMOS
Health Insurance Coverage Mandates
Health Insurance Plan Management and Operations
- A.879/S.599 – Clinical Peer Reviewer
- A.4668/S.4111 – Prohibit Mid-Year Drug Formulary Changes
- S.2008 – Notice of Partial Approval
- S.5299/A.1741 – Copay Accumulator
- S.21210-B/A.289-B – Medically Fragile Children
Pharmaceuticals
- S.3566/A.5854A – Mail Order Pharmacy
- S.4532/A.4667 – Opioid Abuse Deterrent
- S.7252 – “White Bagging”
- S.6603/A.7598 – Managed Care Organizations and Pharmacy Benefit Manager Fees
- A.372/S.5960 – Prohibit Opiod Treatment Program Copay
- S.1413/A.2382 – Capping Cost Sharing for Insulin
Provider Rights and Reimbursement
- A.1523/S.2212 – CHP Discrimination Against Non-Par Providers
- A.1316/S.1573 – Behavioral Health Contracts
- A.5185/S.2533 – Home Care Prompt Pay
- S.5505/A.6256 – Telehealth Payment Parity
- A.5368A – Durable Medical Equipment Reimbursement Parity
- S.3556 – Non Participating Ambulance Reimbursement
Miscellaneous
2020 LEGISLATIVE MEMOS
Health Insurance Plan Management and Operations
- A.9086/S.7525 – Nursing Home Eligibility Determinations
- A.9085/S.7159 – Notice of Partial Approval
- A.2832/S.67 – Domestic Violence Victim Request for Alternative Contact
- A.3076/S.8844 – Clinical Peer Review
- A.9003/S.7569 – Complex Rehabilitation Technology for Medicaid
- S.1408A – Municipality to Join County Self-Insured Plan
Pharmaceuticals
- S.7115/A.9034 – Partial Fill Authorization
- A.10821/S.8255 – $30 Insulin Out of Pocket Cap
- A.8665/S.6646 – Online EPIC Application
- S.6397 – Abuse Deterrent Formulations for Opioids
- S.7109/A.9012 – Medicaid Prescription Synchronization
- S.6492A/A.8533 – $100 Insulin Out of Pocket Cap
- A.9634/S.7699 – Medicaid Managed Care Coverage of Medication Assisted Treatment
- A.9902/S.7828 – Pharmacy Benefit Manager Fiduciary and Licensure
Provider Rights and Reimbursement